FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

Randomized data comparing triple therapy with dual inhaled corticosteroid (ICS)/long-acting β -agonist (LABA) therapy in patients with chronic obstructive pulmonary disease (COPD) are limited. We compared the effects of once-daily triple therapy on lung function and health-related quality of life wi...

Full description

Saved in:

Bibliographic Details
Published in:	American journal of respiratory and critical care medicine Vol. 196; no. 4; pp. 438 - 446
Main Authors:	Lipson, David A., Barnacle, Helen, Birk, Ruby, Brealey, Noushin, Locantore, Nicholas, Lomas, David A., Ludwig-Sengpiel, Andrea, Mohindra, Rajat, Tabberer, Maggie, Zhu, Chang-Qing, Pascoe, Steven J.
Format:	Journal Article
Language:	English
Published:	United States American Thoracic Society 15.08.2017
Subjects:	Administration, Inhalation Androstadienes - therapeutic use Benzyl Alcohols - therapeutic use Bronchodilator Agents - therapeutic use Budesonide - therapeutic use Chlorobenzenes - therapeutic use Chronic obstructive pulmonary disease Clinical medicine Clinical trials Double-Blind Method Drug Administration Schedule Drug dosages Drug Therapy, Combination Female Forced Expiratory Volume - drug effects Formoterol Fumarate - therapeutic use Health risk assessment Humans Lung diseases Male Middle Aged Nebulizers and Vaporizers Patients Pulmonary Disease, Chronic Obstructive - drug therapy Quality of Life Quinuclidines - therapeutic use health-related quality of life lung function single-inhaler triple therapy chronic obstructive pulmonary disease
ISSN:	1073-449X, 1535-4970, 1535-4970
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!